Reports
Reports
The global hallux valgus treatment market size attained a value of about USD 23.43 million in 2022. It is anticipated to grow at a CAGR of 5.90% during the forecast period of 2023-2031 to attain a value of USD 39.39 million by 2031. The growth of the market can be attributed to the increasing prevalence of the condition and the growing investment in research and development activities.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global hallux valgus treatment market is anticipated to witness significant growth in the coming years due to the increasing prevalence of the condition and the growing demand for minimally invasive surgical procedures. Hallux Valgus is a condition that affects the alignment of the big toe, causing it to bend towards the other toes, leading to pain and discomfort.
The hallux valgus treatment market is highly competitive, with key players focusing on research and development activities to develop innovative products and strengthen their market position. The market is characterized by the presence of both global and regional players.
The market can be categorised into type, treatment, diagnosis, route of administration, treatment channel, and region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Type
Market Breakup by Treatment
Market Breakup by Diagnosis
Market Breakup by Route of Administration
Market Breakup by Treatment Channel
Hallux Valgus Treatment Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global hallux valgus treatment market is expected to witness significant growth during the forecast period of 2023-2031. The market is driven by factors such as the increasing prevalence of Hallux Valgus, growing demand for minimally invasive surgical procedures, and the availability of advanced healthcare infrastructure in developed countries. Additionally, the rising incidence of obesity and aging population are also contributing to the growth of the market.
North America dominates the hallux valgus treatment market, followed by Europe and the Asia Pacific. The market in North America is driven by the high prevalence of Hallux Valgus and the availability of advanced healthcare infrastructure. The market in Europe is also expected to grow significantly, with key players focusing on research and development activities to develop innovative products. The market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period, owing to the increasing awareness about Hallux Valgus and the rising healthcare expenditure in the region.
The report gives an in-depth analysis of the key players involved in the hallux valgus treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2016-2022 |
Forecast Period | 2023-2031 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Treatment |
|
Breakup by Diagnosis |
|
Breakup by Route of Administration |
|
Breakup by Treatment Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
2 Research Methodology
3 Executive Summary
4 Hallux Valgus Overview
4.1 Guidelines and Stages
4.2 Pathophysiology
4.3 Screening and Diagnosis
4.4 Treatment Pathway
5 Patient Profile
5.1 Patient Profile Overview
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Treatment Success Rate
6 Current Scenario Evaluation and Regulatory Framework
6.1 Emerging Therapies and Clinical Trials Synopsis
6.2 Patent Landscape
6.2.1 Patent Overview
6.2.1.1 Patent Status and Expiry
6.2.1.2 Timelines from Drug Development to Commercial Launch
6.2.1.3 New Drug Application
6.2.1.3.1 Documentation and Approval Process
6.3 Cost of Treatment
6.4 Regulatory Framework
6.4.1 Regulatory Overview
6.4.1.1 US FDA
6.4.1.2 EU EMA
6.4.1.3 INDIA CDSCO
6.4.1.4 JAPAN PMDA
6.4.1.5 Others
7 Challenges and Unmet Needs
7.1 Treatment Pathway Challenges
7.2 Compliance and Drop-Out Analysis
7.3 Awareness and Prevention Gaps
8 Global Hallux Valgus Treatment Market
8.1 Global Hallux Valgus Treatment Market Overview
8.2 Global Hallux Valgus Treatment Market Analysis
8.2.1 Market Overview
8.2.1.1 Global Hallux Valgus Treatment Market Historical Value (2016-2022)
8.2.1.2 Global Hallux Valgus Treatment Market Forecast Value (2023-2031)
8.3 Global Hallux Valgus Treatment Market by Type
8.3.1 Market Overview
8.3.1.1 Congenital Hallux Valgus
8.3.1.2 Juvenile or Adolescent’s Hallux Valgus
8.3.1.3 Tailer’s Bunion
8.4 Global Hallux Valgus Treatment Market by Treatment
8.4.1 Market Overview
8.4.1.1 Surgical and Mechanical treatment
8.4.1.2 Self-Care
8.4.1.3 Medications
8.4.1.4 Devices
8.4.1.5 Others
8.5 Global Hallux Valgus Treatment Market by Diagnosis
8.5.1 Market Overview
8.5.1.1 X-Rays
8.5.1.2 Medical History
8.5.1.3 Physical Examination
8.5.1.4 Radiography
8.5.1.5 Others
8.6 Global Hallux Valgus Treatment Market by Route of Administration
8.6.1 Market Overview
8.6.1.1 Oral
8.6.1.2 Parenteral
8.6.1.3 Others
8.7 Global Hallux Valgus Treatment Market by Treatment Channel
8.7.1 Public
8.7.2 Private
8.8 Global Hallux Valgus Treatment Market by Region
8.8.1 Market Overview
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 North America Hallux Valgus Treatment Market
9.1 Market Share by Country
9.2 United States of America
9.2.1 Historical Trend (2016-2022)
9.2.2 Forecast Trend (2023-2031)
9.3 Canada
9.3.1 Historical Trend (2016-2022)
9.3.2 Forecast Trend (2023-2031)
10 Europe Hallux Valgus Treatment Market
10.1 Market Share by Country
10.2 United Kingdom
10.2.1 Historical Trend (2016-2022)
10.2.2 Forecast Trend (2023-2031)
10.3 Germany
10.3.1 Historical Trend (2016-2022)
10.3.2 Forecast Trend (2023-2031)
10.4 France
10.4.1 Historical Trend (2016-2022)
10.4.2 Forecast Trend (2023-2031)
10.5 Italy
10.5.1 Historical Trend (2016-2022)
10.5.2 Forecast Trend (2023-2031)
10.6 Others
11 Asia Pacific Hallux Valgus Treatment Market
11.1 Market Share by Country
11.2 China
11.2.1 Historical Trend (2016-2022)
11.2.2 Forecast Trend (2023-2031)
11.3 Japan
11.3.1 Historical Trend (2016-2022)
11.3.2 Forecast Trend (2023-2031)
11.4 India
11.4.1 Historical Trend (2016-2022)
11.4.2 Forecast Trend (2023-2031)
11.5 ASEAN
11.5.1 Historical Trend (2016-2022)
11.5.2 Forecast Trend (2023-2031)
11.6 Australia
11.6.1 Historical Trend (2016-2022)
11.6.2 Forecast Trend (2023-2031)
11.7 Others
12 Latin America Hallux Valgus Treatment Market
12.1 Market Share by Country
12.2 Brazil
12.2.1 Historical Trend (2016-2022)
12.2.2 Forecast Trend (2023-2031)
12.3 Argentina
12.3.1 Historical Trend (2016-2022)
12.3.2 Forecast Trend (2023-2031)
12.4 Mexico
12.4.1 Historical Trend (2016-2022)
12.4.2 Forecast Trend (2023-2031)
12.5 Others
13 Middle East and Africa Hallux Valgus Treatment Market
13.1 Market Share by Country
13.2 Saudi Arabia
13.2.1 Historical Trend (2016-2022)
13.2.2 Forecast Trend (2023-2031)
13.3 United Arab Emirates
13.3.1 Historical Trend (2016-2022)
13.3.2 Forecast Trend (2023-2031)
13.4 Nigeria
13.4.1 Historical Trend (2016-2022)
13.4.2 Forecast Trend (2023-2031)
13.5 South Africa
13.5.1 Historical Trend (2016-2022)
13.5.2 Forecast Trend (2023-2031)
13.6 Others
14 Global Hallux Valgus Treatment Market Dynamics
14.1 Market Drivers and Constraints
14.2 SWOT Analysis
14.3 Porter’s Five Forces Model
14.4 Key Demand Indicators
14.5 Key Price Indicators
14.6 Industry Events, Initiatives and Trends
14.7 Value Chain Analysis
15 Supplier Landscape
15.1 Wright Medical Group N.V.
15.1.1 Company Overview
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.1.5 Certifications
15.2 Smith & Nephew plc
15.2.1 Company Overview
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Zimmer Biomet Holdings, Inc
15.3.1 Company Overview
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Arthrex, Inc.
15.4.1 Company Overview
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Stryker Corporation
15.5.1 Company Overview
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Ossur Hf
15.6.1 Company Overview
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 OrthoHelix Surgical Designs
15.7.1 Company Overview
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Orthofix Holdings Inc
15.8.1 Company Overview
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Mondeal Medical System GmbH
15.9.1 Company Overview
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 BioPro Inc
15.10.1 Company Overview
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
16 Global Hallux Valgus Treatment Market- Drug Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of nearly USD 23.43 million in 2022, driven by the driven by the increasing prevalence of the condition across the globe.
The market is likely to grow at a CAGR of 5.90% during the forecast period of 2023-2031 to attain a value of USD 39.39 million by 2031.
The factors stimulating the development of the market include increased government initiatives, optimal costs, and a rise in R&D expenditure in biopharmaceutical companies.
Fewer drug approvals, stringent government regulations, and lack of awareness are some of the suspected reasons responsible for hindering the growth of the market.
The global market is currently dominated by North America due to the higher presence of key players in the region.
The top companies involved are Tornier N.V., Integra Life Sciences Holdings Corporation, Wright Medical Technology, Inc., Smith & Nephew Plc, Zimmer Biomet Holdings, Inc, Arthrex, Inc., Stryker Corporation, Ossur, Biomet Inc, OrthoHelix Surgical Designs, Orthofix Holdings Inc, Acumen, Mondeal Medical System GmbH, and BioPro Inc.
The most common progressive deformity of the forefoot is hallux valgus, widely known as bunion. Bunions are bumpy growths near the metatarsophalangeal (MTP) joint of the big toe.
Non-surgical treatment of hallux valgus cannot correct the deformity.
Hallux valgus is a genetic disorder and often runs in families. It is commonly seen in patients with excessive pronation who often wear narrow shoes.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.